Notice of Full Year Results

RNS Number : 9684G

e-Therapeutics plc

10 March 2015

 

e-Therapeutics plc

('e-Therapeutics' or 'the Company') 

Notification of Full Year Results Date

Oxford and Newcastle, UK - 10 March 2015 - e-Therapeutics plc (AIM: ETX), the drug discovery and development company, will announce its full year results for the period ended 31 January 2015 on Tuesday, 31 March 2015.

A group analyst briefing will be held at 11:30am on Tuesday, 31 March 2015 at Instinctif Partners' offices at 65 Gresham Street, London EC2V 7NQ.

Analysts who wish to participate should contact Instinctif Partners on [phone] or email

[e-mail] to register.

-Ends-

Contacts:

e-Therapeutics plc

Steve Medlicott

Tel: [phone]

www.etherapeutics.co.uk 

N+1 Singer

Aubrey Powell / Jen Boorer

Tel: [phone]

www.n1singer.com 

Instinctif Partners

Melanie Toyne-Sewell / Emma Barlow

Tel: [phone]

Email: [e-mail]

About e-Therapeutics plc

e-Therapeutics is an AIM-quoted drug discovery and development company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on advances in network science and chemical biology. The Company's discovery and development activity is currently focused in cancer and disorders of the nervous system.

e-Therapeutics is based at sites in Oxford and Newcastle, UK. For more information about the Company, please visit www.etherapeutics.co.uk.

 

END

 

 

NORFKLLBEXFBBBV